PDF(4487 KB)
Effects of monocyte chemoattractant protein-1 on invasion and migration of lung cancer A549 and their mechanisms
Yuan WANG,Zhijuan WANG,Mingshu ZHANG,Yihui WANG,Qing ZHANG,Liping YE
PDF(4487 KB)
PDF(4487 KB)
Effects of monocyte chemoattractant protein-1 on invasion and migration of lung cancer A549 and their mechanisms
)Objective To discuss the effects of monocyte chemoattractant protein-1 （MCP-1） on the migration and invasion of lung cancer A549 cells， and to clarify the mechanisms. Methods Immunohistochemistry method was used to detect the expression of MCP-1 protein in 80 cases of non-small cell lung cancer （NSCLC） and adjacent normal lung tissues. The human lung cancer A549 cells were cultured in vitro. The MCP-1-small interfering RNA （siRNA） experiment was divided into blank group， negative control group （si-NC group）， MCP-1-siRNA-1 group， and MCP-1-siRNA-2 group. The MCP-1 over-expression experiment was divided into control group， empty vector control group （OE-NC， transfected with MCP-1 over-expression empty vector）， over-expression MCP-1 group （OE-MCP-1 group， transfected with MCP-1 over-expression plasmid）， over-expression MCP-1+extracellular regulated protein kinase （ERK） pathway inhibitor PD98059 group （OE-MCP-1+PD98059 group， co-transfected with MCP-1 over-expression plasmid and PD98059）， and PD98059 group （transfected with PD98059）.The MCP-1 siRNA and plasmids were transfected into the lung cancer A549 cells； Western blotting method was used to verify the transfection efficiencies of the cells in various groups； the migration rate and the number of invasion cells in various groups were observed by wound healing assay and Transwell chamber assay， respectively； Western blotting method was also used to detect the expression levels of phosphorylated ERK （p-ERK）， total ERK （t-ERK）， and epithelial-mesenchymal transition （EMT）-related proteins in the A549 cells in various groups. Results Compared with adjacent tissue， the positive expression rate of MCP-1 protein in NSCLC tissue was significantly increased （P<0.05）， and the expression level of MCP-1 protein was related to TNM stage and lymph node metastasis （P<0.05）. Compared with si-NC group， the expression level of MCP-1 protein in the cells in MCP-1-siRNA-1 and MCP-1-siRNA-2 groups was significantly decreased （P<0.01）. Compared with control group and OE-NC group， the expression level of MCP-1 protein in the cells in OE-MCP-1 group was significantly increased （P<0.01）. The wound healing assay results showed that compared with si-NC group， the migration rate of the cells in MCP-1-siRNA-1 and MCP-1-siRNA-2 groups were significantly decreased （P<0.01）. Compared with OE-NC group， the migration rate of the cells in OE-MCP-1 group was significantly increased （P<0.01）； compared with OE-MCP-1 group， the migration rate of the cells in OE-MCP-1+PD98059 group was significantly decreased （P<0.01）. Compared with OE-MCP-1+PD98059 group， the migration rate of the cells in PD98059 group was significantly decreased （P<0.01）. The Transwell chamber assay results showed that compared with si-NC group， the number of invasion cells in MCP-1-siRNA-1 and MCP-1-siRNA-2 groups was significantly decreased （P<0.01）. Compared with OE-NC group， the number of invasion cells in OE-MCP-1 group was significantly increased （P<0.01）； compared with OE-MCP-1 group， the number of invasion cells in OE-MCP-1+PD98059 group was significantly decreased （P<0.01）； compared with OE-MCP-1+PD98059 group， the number of invasion cells in PD98059 group was significantly decreased （P<0.01）.The Western blotting results showed that compared with si-NC group， the expression levels of p-ERK， Vimentin， and N-cadherin protein in the cells in MCP-1-siRNA-1 and MCP-1-siRNA-2 groups were significantly decreased （P<0.05 or P<0.01）， and the expression level of E-cadherin proteins was significantly increased （P<0.01）. Compared with OE-NC group， the expression levels of p-ERK， Vimentin， and N-cadherin proteins in the cells in OE-MCP-1 group were significantly increased （P<0.01）， and the expression level of E-cadherin protein was significantly decreased （P<0.01）. Compared with OE-MCP-1 group， the expression levels of p-ERK， Vimentin， and N-cadherins proteins in the OE-MCP-1+PD98059 group were significantly decreased （P<0.01）， and the expression level of E-cadherin protein was significantly increased （P<0.05）. Compared with OE-MCP-1+PD98059 group， the expression levels of p-ERK， Vimentin， and N-cadherin proteins in the cells in PD98059 group were significantly decreased （P<0.05 or P<0.01）， and the expression level of E-cadherin protein was increased （P<0.01）. Conclusion MCP-1 protein can upregulate the expression of EMT-related proteins in the lung cancer A549 cells， and promote the migration and invasion of the lung cancer A549 cells； its mechanism may be related to the activation of the ERK signaling pathway.
Monocyte chemoattractant protein-1 / Extracellular-signal regulated protein kinase / Cancer，non-small cell lung / Cell invasion / Cell migration
R734.2
| 1 | SUNG H， FERLAY J， SIEGEL R L， et al. Global cancer statistics 2020： GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］. CA Cancer J Clin， 2021， 71（3）： 209-249. |
| 2 | DE LA FUENTE LóPEZ M， LANDSKRON G， PARADA D， et al. The relationship between chemokines CCL2， CCL3， and CCL4 with the tumor microenvironment and tumor-associated macrophage markers in colorectal cancer［J］. Tumour Biol， 2018， 40（11）： 1010428318810059. |
| 3 | FANG W B， JOKAR I， ZOU A， et al. CCL2/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein- and p42/44 mitogen-activated protein kinase （MAPK）-dependent mechanisms［J］. J Biol Chem， 2012， 287（43）： 36593-36608. |
| 4 | LIU W， WANG L， ZHANG J J， et al. Purification of recombinant human chemokine CCL2 in E. coli and its function in ovarian cancer［J］. 3 Biotech， 2021， 11（1）： 8. |
| 5 | THOMAS M U， MESSEX J K， DANG T， et al. Macrophages expedite cell proliferation of prostate intraepithelial neoplasia through their downstream target ERK［J］. FEBS J， 2021， 288（6）： 1871-1886. |
| 6 | MITTAL P， WANG L Q， AKIMOVA T， et al. The CCR2/MCP-1 chemokine pathway and lung adenocarcinoma［J］. Cancers， 2020， 12（12）： 3723. |
| 7 | ALTORKI N K， MARKOWITZ G J， GAO D C， et al. The lung microenvironment： an important regulator of tumour growth and metastasis［J］. Nat Rev Cancer， 2019， 19（1）： 9-31. |
| 8 | PAUSCH T M， AUE E， WIRSIK N M， et al. Metastasis-associated fibroblasts promote angiogenesis in metastasized pancreatic cancer via the CXCL8 and the CCL2 axes［J］. Sci Rep， 2020， 10（1）： 5420. |
| 9 | FENG L， QI Q， WANG P， et al. Serum level of CCL2 predicts outcome of patients with pancreatic cancer［J］. Acta Gastroenterol Belg， 2020， 83（2）： 295-299. |
| 10 | LI Y L， SHI Z H， WANG X， et al. Prognostic significance of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in diffuse large B cell lymphoma［J］. Ann Hematol， 2019， 98（2）： 413-422. |
| 11 | HEISKALA M， LEIDENIUS M， JOENSUU K， et al. High expression of CCL2 in tumor cells and abundant infiltration with CD14 positive macrophages predict early relapse in breast cancer［J］. Virchows Arch， 2019， 474（1）： 3-12. |
| 12 | LI L， LIU Y D， ZHAN Y T， et al. High levels of CCL2 or CCL4 in the tumor microenvironment predict unfavorable survival in lung adenocarcinoma［J］. Thorac Cancer， 2018， 9（7）： 775-784. |
| 13 | MANFIOLETTI G， FEDELE M. Epithelial-mesenchymal transition （EMT） 2021［J］. Int J Mol Sci， 2022， 23（10）： 5848. |
| 14 | HUANG Y H， HONG W Q， WEI X W. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis［J］. J Hematol Oncol， 2022， 15（1）： 129. |
| 15 | DONG Y Q， ZHANG S N， ZHAO S Y， et al. CCL2 promotes lymphatic metastasis via activating RhoA and Rac1 pathway and predict prognosis to some extent in tongue cancer［J］. Cancer Biol Ther， 2023， 24（1）：2205342. |
| 16 | LING Z H， YANG X， CHEN X B， et al. CCL2 promotes cell migration by inducing epithelial-mesenchymal transition in oral squamous cell carcinoma［J］. J Oral Pathol Med， 2019， 48（6）： 477-482. |
| 17 | CHEN X Z， YANG M Q， YIN J， et al. Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling［J］. Cell Commun Signal， 2022， 20（1）： 92. |
| 18 | ROBLEK M， PROTSYUK D， BECKER P F， et al. CCL2 is a vascular permeability factor inducing CCR2-dependent endothelial retraction during lung metastasis［J］. Mol Cancer Res， 2019， 17（3）： 783-793. |
| 19 | YAN J， GAO Y P， LIN S， et al. EGR1-CCL2 feedback loop maintains epithelial-mesenchymal transition of cisplatin-resistant gastric cancer cells and promotes tumor angiogenesis［J］. Dig Dis Sci， 2022， 67（8）： 3702-3713. |
| 20 | ZHONG Y Z， LIN Z C， LU J H， et al. CCL2-CCL5/CCR4 contributed to radiation-induced epithelial-mesenchymal transition of HPAEpiC cells via the ERK signaling pathways［J］. Am J Transl Res， 2019， 11（2）： 733-743. |
/
| 〈 |
|
〉 |
AI Summary
